Dynavax Technologies Corp.
(NASDAQ : DVAX)

( )
DVAX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-3.26%281.891.4%$828.75m
AMGNAmgen, Inc.
-0.74%219.671.3%$498.30m
CELGCelgene Corp.
0.37%110.411.3%$456.70m
GILDGilead Sciences, Inc.
-0.03%63.311.0%$378.94m
ILMNIllumina, Inc.
0.84%298.223.5%$303.22m
VRTXVertex Pharmaceuticals, Inc.
1.59%207.101.9%$299.78m
REGNRegeneron Pharmaceuticals, Inc.
-0.03%348.302.6%$264.62m
EXASEXACT Sciences Corp.
-2.08%78.2524.0%$194.88m
ALXNAlexion Pharmaceuticals, Inc.
-2.11%107.132.0%$183.19m
SGENSeattle Genetics, Inc.
1.42%112.216.1%$131.55m
BMRNBioMarin Pharmaceutical, Inc.
0.34%76.144.3%$116.24m
SRPTSarepta Therapeutics, Inc.
1.05%101.0014.6%$115.43m
AAgilent Technologies, Inc.
0.13%77.151.6%$101.09m
MRTXMirati Therapeutics, Inc.
-3.45%100.732.3%$86.61m
NBIXNeurocrine Biosciences, Inc.
-0.44%110.915.0%$85.67m

Company Profile

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.